Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "696ddf1a8f7ed3c5c7df9f01", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Eltrombopag Olamine Tablets 50 mg", "description": "Eltrombopag Olamine Tablets 50 mg, marketed under the brand name LTROLAMINE 50, is a prescription medicine widely used in the management of low platelet count (thrombocytopenia) associated with certain blood disorders. It belongs to a class of medicines known as thrombopoietin receptor agonists, which work by stimulating platelet production in the bone marrow.\n\nLTROLAMINE 50 has become an important therapeutic option for patients who struggle with chronic platelet deficiency and are at increased risk of bleeding. With proven efficacy and a well-defined mechanism of action, this medication plays a crucial role in improving patient outcomes and quality of life.\n\nWhat is Eltrombopag Olamine Tablets 50 mg?\n\nEltrombopag Olamine Tablets 50 mg is an oral medication designed to increase platelet counts in patients whose body does not produce enough platelets naturally. Platelets are essential blood components responsible for clot formation and prevention of excessive bleeding.\n\nLTROLAMINE 50 is commonly prescribed for:\n\nChronic Immune Thrombocytopenia (ITP)\n\nSevere Aplastic Anemia\n\nThrombocytopenia associated with chronic Hepatitis C infection (in specific cases)\n\nBy improving platelet levels, LTROLAMINE 50 helps reduce bleeding risks and supports safer daily functioning for patients.\n\nUses of LTROLAMINE 50\n\nLTROLAMINE 50 is primarily used in the treatment of conditions characterized by low platelet counts, including:\n\n1. Chronic Immune Thrombocytopenia (ITP)\n\nIn patients with ITP, the immune system mistakenly destroys platelets. LTROLAMINE 50 stimulates platelet production, helping maintain a safer platelet count and lowering the risk of spontaneous bleeding.\n\n2. Severe Aplastic Anemia\n\nIn aplastic anemia, the bone marrow fails to produce sufficient blood cells. Eltrombopag Olamine supports bone marrow activity, leading to improved platelet and blood cell production when other treatments are ineffective.\n\n3. Hepatitis C–Associated Thrombocytopenia\n\nSome patients with chronic Hepatitis C experience low platelet counts that limit antiviral therapy. LTROLAMINE 50 may be used to raise platelet levels, enabling continuation of essential treatment under medical supervision.\n\nHow LTROLAMINE 50 Works\n\nEltrombopag Olamine acts as a thrombopoietin receptor agonist. It binds to and activates the thrombopoietin (TPO) receptor found on bone marrow cells. This activation triggers a signaling process that stimulates the production of megakaryocytes—the cells responsible for forming platelets.\n\nUnlike platelet transfusions, which provide a temporary solution, LTROLAMINE 50 encourages the body to produce its own platelets, offering a more sustainable approach to managing thrombocytopenia.\n\nKey Benefits of LTROLAMINE 50\n\nLTROLAMINE 50 offers several clinically significant benefits:\n\n1. Increases Platelet Count Naturally\n\nBy stimulating bone marrow activity, LTROLAMINE 50 helps raise platelet levels without relying on transfusions.\n\n2. Reduces Bleeding Risk\n\nMaintaining adequate platelet counts significantly lowers the risk of bruising, nosebleeds, gum bleeding, and internal bleeding.\n\n3. Oral and Convenient Therapy\n\nAs an oral tablet, LTROLAMINE 50 is easy to administer and more comfortable for long-term use compared to injectable alternatives.\n\n4. Improves Quality of Life\n\nBy stabilizing platelet levels, patients can lead more active, confident lives with fewer hospital visits.\n\n5. Useful in Refractory Cases\n\nLTROLAMINE 50 is effective even in patients who do not respond adequately to first-line therapies like corticosteroids or immunoglobulins.\n\nDosage and Administration\n\nThe dosage of LTROLAMINE 50 is determined by the treating physician based on:\n\nPlatelet count\n\nUnderlying condition\n\nLiver function\n\nPatient response to therapy\n\nThe tablet is usually taken once daily, preferably on an empty stomach. Certain foods and supplements, especially those containing calcium, iron, magnesium, or aluminum, may interfere with absorption and should be avoided close to dosing time.\n\nPatients must strictly follow medical advice and undergo regular blood tests to monitor platelet levels and liver function.\n\nPossible Side Effects of LTROLAMINE 50\n\nLike all medicines, LTROLAMINE 50 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects\n\nHeadache\n\nNausea or vomiting\n\nFatigue\n\nDiarrhea\n\nMuscle or joint pain\n\nThese effects are generally mild and tend to improve as the body adjusts to the medication.\n\nLess Common but Serious Side Effects\n\nElevated liver enzymes\n\nRisk of blood clots if platelet counts become too high\n\nLiver function abnormalities\n\nCataract development with long-term use (rare)\n\nPatients should immediately inform their healthcare provider if they notice symptoms such as yellowing of the skin or eyes, severe abdominal pain, chest pain, or sudden swelling in limbs.\n\nPrecautions and Warnings\n\nLTROLAMINE 50 should only be used under strict medical supervision.\n\nRegular blood tests are essential to avoid excessive platelet increase.\n\nCaution is advised in patients with liver disease.\n\nPregnant or breastfeeding women should consult their doctor before use.\n\nThe medicine should not be stopped abruptly without medical advice.\n\nConclusion\n\nEltrombopag Olamine Tablets 50 mg (LTROLAMINE 50) is a clinically proven and effective therapy for managing thrombocytopenia associated with serious blood disorders. By stimulating the body’s natural platelet production, LTROLAMINE 50 helps reduce bleeding risk, minimize hospital dependence, and improve overall patient well-being.", "price": 1640.0, "discountamount": 492.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2279, "imageuri": "https://productimages.withfloats.com/actual/696ddf1b2b30597eb3c9bc2a.png", "tileimageuri": "https://productimages.withfloats.com/tile/696ddf1b2b30597eb3c9bc2a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-19T07:36:58.313Z", "updatedon": "2026-03-14T06:47:29.988Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/eltrombopag-olamine-tablets-50-mg/2279", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LTROLAMINE 50", "category": "GENERAL RANGE", "tags": [ "eltrombopag olamine tablets 50 mg", "eltrombopag 50 mg tablet uses", "eltrombopag olamine 50 mg tablets", "eltrombopag 50 mg dosage", "eltrombopag olamine tablet 50 mg price", "eltrombopag 50 mg tablet in India", "eltrombopag olamine tablets 50 mg for ITP", "eltrombopag 50 mg tablets for low platelet count", "eltrombopag olamine 50 mg tablets uses and benefits", "eltrombopag 50 mg tablet side effects", "how eltrombopag 50 mg works", "eltrombopag olamine tablets 50 mg mechanism of action", "eltrombopag 50 mg tablets for thrombocytopenia", "what is eltrombopag olamine 50 mg tablet", "eltrombopag 50 mg tablets indications", "eltrombopag olamine tablets 50 mg precautions", "eltrombopag 50 mg tablet dosage guidelines", "eltrombopag olamine tablets 50 mg safety profile", "buy eltrombopag olamine tablets 50 mg online", "eltrombopag 50 mg tablets wholesale supplier India", "eltrombopag olamine tablets 50 mg pharma company", "eltrombopag 50 mg tablets manufacturer in India", "eltrombopag olamine 50 mg tablets cost" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "696dda0f911df6d4b0db21c2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Eltrombopag Olamine Tablets 25 mg", "description": "LTROLAMINE 25 is a prescription medicine containing Eltrombopag Olamine Tablets 25 mg, developed to support patients suffering from low platelet count (thrombocytopenia). Platelets play a vital role in blood clotting, and a reduced platelet count can significantly increase the risk of bleeding and related complications. LTROLAMINE 25 works by stimulating platelet production in the bone marrow, thereby helping the body maintain a healthier platelet level and reducing bleeding risks.\n\nEltrombopag Olamine is widely used in hematology and liver-related disorders where platelet deficiency is a major concern. LTROLAMINE 25 is formulated with precision to ensure effectiveness, safety, and consistent therapeutic outcomes when used under medical supervision.\n\nWhat is Eltrombopag Olamine Tablets 25 mg?\n\nEltrombopag Olamine is an oral thrombopoietin receptor agonist. It mimics the action of thrombopoietin, a natural hormone responsible for regulating platelet production. By activating thrombopoietin receptors on bone marrow cells, Eltrombopag increases platelet formation and release into the bloodstream.\n\nLTROLAMINE 25 is available in tablet form, making it convenient for long-term management of chronic platelet disorders.\n\nUses of LTROLAMINE 25\n\nLTROLAMINE 25 is primarily prescribed for conditions associated with low platelet counts, including:\n\nChronic Immune Thrombocytopenia (ITP)\nUsed in adults and children who do not respond adequately to corticosteroids, immunoglobulins, or splenectomy.\n\nAplastic Anemia\nHelps stimulate platelet production in patients with severe aplastic anemia who have not responded to immunosuppressive therapy.\n\nHepatitis C–Related Thrombocytopenia\nSupports patients with chronic hepatitis C by improving platelet count, enabling them to receive antiviral therapy safely.\n\nBone Marrow Disorders\nAssists in managing thrombocytopenia caused by bone marrow suppression or dysfunction.\n\nHow LTROLAMINE 25 Works\n\nEltrombopag Olamine works by binding to thrombopoietin receptors (TPO receptors) found on bone marrow precursor cells. Once activated, these receptors stimulate the growth and differentiation of megakaryocytes, which are responsible for producing platelets.\n\nMechanism of Action\n\nActivates thrombopoietin receptors\n\nIncreases megakaryocyte proliferation\n\nEnhances platelet production\n\nImproves circulating platelet count\n\nReduces bleeding risk\n\nUnlike platelet transfusions, LTROLAMINE 25 supports the body’s natural platelet production process, making it suitable for long-term therapy.\n\nKey Benefits of LTROLAMINE 25\n\nEffectively Raises Platelet Count\nHelps maintain platelet levels within a safer range, reducing the need for frequent transfusions.\n\nOral Administration\nTablet form ensures ease of use and better patient compliance.\n\nLong-Term Management\nSuitable for chronic conditions like ITP and aplastic anemia.\n\nReduces Bleeding Risk\nLower chances of spontaneous bleeding, bruising, or internal hemorrhage.\n\nImproves Quality of Life\nPatients experience greater confidence in daily activities with reduced bleeding concerns.\n\nClinically Proven Molecule\nEltrombopag is supported by extensive clinical research in hematological disorders.\n\nDosage and Administration\n\nThe dosage of LTROLAMINE 25 is decided by the treating physician based on:\n\nPatient’s age and weight\n\nPlatelet count\n\nUnderlying medical condition\n\nLiver function status\n\nGeneral Guidelines\n\nTaken once daily on an empty stomach\n\nShould be taken at least 2 hours before or 4 hours after dairy products, calcium, iron, or mineral supplements\n\nDose adjustments are done based on platelet response\n\n⚠️ Always follow the doctor’s prescription and do not self-adjust the dose.\n\nPossible Side Effects of LTROLAMINE 25\n\nLike all medicines, LTROLAMINE 25 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects\n\nHeadache\n\nNausea\n\nFatigue\n\nDiarrhea\n\nMuscle or joint pain\n\nUpper respiratory tract infections\n\nLess Common but Serious Side Effects\n\nIncreased liver enzymes\n\nBlood clots (if platelet count rises excessively)\n\nCataract formation (with long-term use)\n\nLiver function abnormalities\n\nPatients are advised to undergo regular blood tests to monitor platelet levels and liver function while on LTROLAMINE 25.\n\nPrecautions & Warnings\n\nNot recommended without medical supervision\n\nCaution in patients with liver disease\n\nRegular monitoring of platelet count is essential\n\nShould not be used during pregnancy unless clearly advised\n\nAvoid sudden discontinuation, as platelet count may drop rapidly\n\nInform your doctor about all other medications you are taking to prevent interactions.\n\nStorage Instructions\n\nStore below 30°C\n\nKeep away from moisture and direct sunlight\n\nKeep out of reach of children\n\nConclusion\n\nLTROLAMINE 25 (Eltrombopag Olamine Tablets 25 mg) is a reliable and effective treatment option for patients suffering from thrombocytopenia due to various medical conditions. By stimulating natural platelet production, it reduces bleeding risk, improves treatment outcomes, and enhances overall quality of life. Its oral formulation, proven efficacy, and role in long-term platelet management make LTROLAMINE 25 a valuable medicine in modern hematology care.", "price": 840.0, "discountamount": 252.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2278, "imageuri": "https://productimages.withfloats.com/actual/696dda15ff3886a07028ae89.png", "tileimageuri": "https://productimages.withfloats.com/tile/696dda15ff3886a07028ae89.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-19T07:15:27.702Z", "updatedon": "2026-04-06T07:18:55.865Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//eltrombopag-olamine-tablets-25-mg/2278", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LTROLAMINE 25", "category": "GENERAL RANGE", "tags": [ "eltrombopag 25 mg tablet supplier india", "eltrombopag olamine tablets wholesale price", "eltrombopag 25 mg tablet buy online india", "eltrombopag olamine tablets 50 mg price", "eltrombopag olamine tablets 50 mg", "eltrombopag olamine tablets", "eltrombopag olamine tablets price in india", "eltrombopag olamine tablets price", "eltrombopag 25 mg uses", "eltrombopag 25 mg brands in india", "eltrombopag 25 mg tablet supplier india", "eltrombopag 25 mg wholesale price india", "eltrombopag 25 mg bulk purchase india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d6df52731125bdd4e1003b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALGANCICLOVIR TABLET 450 MG", "description": "VOLANE SOURCE 450 is a pharmaceutical tablet containing Valganciclovir at a dosage strength of 450 mg. It is a potent antiviral medication primarily designed to treat and prevent certain viral infections caused by cytomegalovirus (CMV), especially in immunocompromised patients such as those undergoing organ transplants or living with HIV/AIDS. Manufactured adhering to strict quality standards under the tablet IP (Indian Pharmacopoeia), VOLANE SOURCE 450 ensures consistent efficacy and safety for patients requiring antiviral therapy.\n\nComposition and Pharmacological Profile\nEach film-coated tablet of VOLANE SOURCE 450 contains 450 mg of Valganciclovir as the active ingredient. Valganciclovir is a prodrug of ganciclovir, meaning it is converted in the body into ganciclovir, which is the active antiviral agent. Its mechanism involves inhibiting viral DNA synthesis by competing with deoxyguanosine triphosphate for incorporation into viral DNA, thereby suppressing the replication of CMV and related herpes viruses.\n\nPrimary Uses of VOLANE SOURCE 450\nTreatment of CMV Retinitis: CMV retinitis is a serious viral eye infection common in patients with weakened immune systems, such as AIDS patients. It leads to inflammation and possible vision loss if left untreated. VOLANE SOURCE 450 is a frontline therapy used to halt the progression of this infection.\n\nPrevention of CMV Disease in Transplant Patients: Solid organ transplant recipients and bone marrow transplant patients are at high risk of CMV infection due to immunosuppressive drugs. Prophylactic use of VOLANE SOURCE 450 helps in preventing CMV disease in these vulnerable groups.\n\nTreatment of CMV Infection: Apart from retinitis, CMV can cause systemic infections affecting multiple organs, including lungs, digestive tract, and nervous system. VOLANE SOURCE 450 is used for managing such infections effectively.\n\nPart of Combination Therapy: It may also be prescribed alongside other antiviral agents as part of combination treatment protocols tailored to complex viral infections, enhancing viral suppression.\n\nKey Benefits of Using VOLANE SOURCE 450\nHigh Oral Bioavailability: Being a prodrug, Valganciclovir is well absorbed orally and converted efficiently to ganciclovir in the body, enabling effective antiviral levels.\n\nWide Spectrum of Action: Targets multiple herpesviruses with high specificity, primarily cytomegalovirus, reducing viral load and infection severity.\n\nReduced Risk of CMV Disease Post-Transplant: By preventing CMV infection in transplant recipients, VOLANE SOURCE 450 significantly lowers the risk of post-transplant complications related to viral disease.\n\nConvenient Oral Dosage: Unlike intravenous ganciclovir, VOLANE SOURCE 450 allows for easier home administration, improving patient compliance and quality of life.\n\nEffective Against Resistant Strains: Used in recurrent and resistant CMV infections, especially where other therapies fail.\n\nProtects Vision: In CMV retinitis patients, prompt use of VOLANE SOURCE 450 can preserve vision and prevent blindness due to viral damage.\n\nRecommended Dosage and Administration\nThe dosing of VOLANE SOURCE 450 depends on the condition being treated, kidney function, and patient immune status. It is typically prescribed by healthcare professionals following careful medical assessment.\n\nFor CMV retinitis treatment, the initial dose is usually higher and then tapered down for maintenance.\n\nFor CMV prophylaxis post-transplant, a standard dose is taken once or twice daily for several months.\n\nIt is advised to swallow tablets whole with food to enhance absorption.\n\nRegular monitoring of blood counts and kidney function is essential during therapy since the drug can impact bone marrow and renal function.\n\nPotential Side Effects of VOLANE SOURCE 450\nLike any potent antiviral medication, VOLANE SOURCE 450 can cause side effects. Awareness and timely reporting to a healthcare provider are important to manage these effects safely.\n\nCommon side effects include:\n\nGastrointestinal symptoms: Nausea, vomiting, diarrhea, and abdominal pain.\n\nBone marrow suppression: Leading to anemia, neutropenia (low neutrophils), or thrombocytopenia (low platelets), which increase infection risks and bruising.\n\nHeadache and fatigue: Mild to moderate headache and tiredness may occur.\n\nFever and infections: Due to immune suppression, secondary infections may arise.\n\nElectrolyte imbalance: Occasionally, abnormalities in blood calcium or potassium levels.\n\nRare hypersensitivity reactions: Skin rash, itching, or swelling which require immediate medical attention.\n\nPrecautions and Contraindications\nPatients with severe renal impairment require dose adjustments or alternative therapies to avoid toxicity.\n\nPregnant or breastfeeding women should avoid this drug due to potential harm to the fetus or infant.\n\nRegular blood tests are necessary to monitor for hematologic or renal side effects.\n\nUse caution in patients with pre-existing neutropenia or anemia.\n\nConclusion\nVOLANE SOURCE 450 (Valganciclovir Tablet IP 450 mg) represents a reliable and efficacious antiviral therapy specifically targeting cytomegalovirus infections. Its role in treatment and prevention of CMV-related diseases, especially among immunocompromised patients, makes it invaluable in clinical practice.\n\nIts oral formulation allows for easy administration and effective drug delivery, improving patient adherence and outcomes. While the risk of side effects exists, careful monitoring and adherence to prescribed dosages minimize complications.\n\nOverall, VOLANE SOURCE 450 offers a potent solution against serious viral infections, helping preserve health, prevent complications, and improve quality of life for vulnerable patient populations.\n\n", "price": 3944.0, "discountamount": 2367.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "viral DNA", "rare cases", "Key Benefits", "CMV Retinitis", "VOLANE SOURCE", "CMV infection", "various organs", "kidney function", "prescribed course", "chain termination", "active ingredient", "organ transplants", "medical condition", "blood cell counts", "healthcare provider", "severe side effects", "Common Side Effects", "Regular blood tests", "complete eradication", "antiviral medication", "high bioavailability", "severe eye infection", "Serious Side Effects", "high-risk individuals", "convenient oral option", "bone marrow suppression", "weakened immune systems", "VALGANCICLOVIR TABLET IP", "High Oral Bioavailability", "Immediate medical attention" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1950, "imageuri": "https://productimages.withfloats.com/actual/6936b55236477d52c1e94700.png", "tileimageuri": "https://productimages.withfloats.com/tile/6936b55236477d52c1e94700.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-03T10:05:06.943Z", "updatedon": "2026-03-12T06:40:40.942Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//valganciclovir-tablet-450-mg/1950", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VOLANE SOURCE 450", "category": "CARDIOLOGYRANGE", "tags": [ "VALGANCICLOVIR TABLET IP 450 MG USUE", "Valganciclovir Tablet IP 450 mg", "infections caused by cytomegalovirus (CMV).", "VOLANE SOURCE 450", "helps control the spread of the CMV infection within the body", "high bioavailability", "improve quality of life for vulnerable patient populations", "valganciclovir tablet 450 mg uses", "valganciclovir 450 mg tablet price in India", "valganciclovir 450 mg dosage information", "valganciclovir tablet 450 mg composition", "valganciclovir 450 mg tablet side effects", "valganciclovir 450 mg tablet benefits", "what is valganciclovir tablet 450 mg used for", "how valganciclovir 450 mg works", "valganciclovir 450 mg tablet mechanism of action", "valganciclovir tablet 450 mg storage instructions", "valganciclovir 450 mg tablet administration guide", "buy valganciclovir 450 mg tablet online", "valganciclovir 450 mg tablet supplier India", "valganciclovir tablet 450 mg wholesale price", "valganciclovir 450 mg tablet manufacturer", "valganciclovir 450 mg tablet distributor", "valganciclovir 450 mg generic tablet", "valganciclovir 450 mg tablet substitute", "valganciclovir 450 mg antiviral tablet", "when to take valganciclovir 450 mg tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662e880ea22b014e8af4003", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "hydroxyurea 500 mg capsule", "description": "HYDROXENA 500\nHydroxyurea 500 mg\nHYDROXENA 500 is a clinically trusted medication formulated with Hydroxyurea 500 mg, widely used in the management of certain cancers and blood-related disorders. It belongs to a class of medicines known as antimetabolites, which work by slowing down or stopping the growth of abnormal cells in the body.\n\nHydroxyurea has been a cornerstone therapy in hematology and oncology for decades due to its proven efficacy in controlling abnormal cell proliferation. HYDROXENA 500 offers a reliable and convenient oral treatment option for patients requiring long-term disease management.\n\nHow HYDROXENA 500 (Hydroxyurea 500 mg) Works\n\nHydroxyurea works by interfering with DNA synthesis in rapidly dividing cells. It inhibits an enzyme called ribonucleotide reductase, which is essential for DNA production. By doing so, it slows down the multiplication of abnormal cells, particularly in cancers and blood disorders.\n\nIn addition, hydroxyurea increases the production of fetal hemoglobin (HbF), which plays a crucial role in reducing complications in patients with sickle cell disease.\n\nThis dual mechanism makes HYDROXENA 500 effective in both oncology and hematology treatments.\n\nUses of HYDROXENA 500\n\nHYDROXENA 500 is prescribed for a variety of medical conditions, including:\n\n1. Sickle Cell Anemia\n\nIt helps reduce the frequency of painful crises and the need for blood transfusions by increasing fetal hemoglobin levels.\n\n2. Chronic Myeloid Leukemia (CML)\n\nUsed to control the excessive production of white blood cells in leukemia patients.\n\n3. Head and Neck Cancer\n\nOften used in combination with radiation therapy to enhance treatment effectiveness.\n\n4. Polycythemia Vera\n\nHelps reduce elevated red blood cell counts, preventing complications like blood clots.\n\n5. Essential Thrombocythemia\n\nControls high platelet counts, lowering the risk of thrombosis.\n\nKey Benefits of HYDROXENA 500\nEffective Cell Growth Control\n\nHYDROXENA 500 slows down abnormal cell division, making it highly effective in cancer and blood disorders.\n\nReduces Sickle Cell Crises\n\nBy increasing fetal hemoglobin, it significantly lowers the frequency and severity of pain episodes.\n\nImproves Blood Parameters\n\nHelps normalize red blood cells, white blood cells, and platelet counts.\n\nOral Convenience\n\nCapsule form allows easy administration without the need for hospital-based treatments.\n\nEnhances Treatment Outcomes\n\nWhen combined with other therapies like radiation, it improves overall effectiveness.\n\nDosage and Administration\nDosage is determined by a healthcare professional based on body weight, medical condition, and response to treatment\nTypically taken once daily with a full glass of water\nCapsules should be swallowed whole and not opened or crushed\n\nImportant Guidelines:\n\nMaintain adequate hydration during treatment\nRegular blood tests are necessary to monitor cell counts\nFollow the prescribed schedule strictly\nSide Effects of HYDROXENA 500\n\nWhile HYDROXENA 500 is effective, it may cause certain side effects. Most are manageable with proper medical supervision.\n\nCommon Side Effects\nNausea and vomiting\nLoss of appetite\nConstipation or diarrhea\nMild skin rash\nModerate Side Effects\nMouth ulcers\nHair thinning\nFatigue or weakness\nSkin darkening or nail changes\nSerious Side Effects (Require Immediate Attention)\nSevere bone marrow suppression (low blood counts)\nIncreased risk of infections\nUnusual bleeding or bruising\nFever or chills\nLong-term use may increase the risk of secondary cancers (rare)\n\nPatients should immediately contact a doctor if they experience persistent fever, unusual bleeding, or severe fatigue.\n\nPrecautions and Warnings\nRegular Blood Monitoring: Essential to avoid complications like low blood cell counts\nPregnancy and Breastfeeding: Not recommended due to potential harm to the fetus or infant\nInfection Risk: Avoid contact with people who have infections\nLiver and Kidney Function: Use cautiously in patients with impaired organ function\nHandling Precautions: Capsules should be handled carefully; avoid direct contact with powder if opened\nStorage Instructions\nStore in a cool, dry place below 25°C\nProtect from moisture and direct sunlight\nKeep out of reach of children\nWhy Choose HYDROXENA 500?\n\nHYDROXENA 500 stands out as a dependable and well-established therapy in both oncology and hematology. Its ability to manage multiple conditions with a single formulation makes it a versatile and valuable medication.\n\nFor healthcare providers and pharmaceutical distributors, HYDROXENA 500 offers strong demand potential due to its wide range of clinical applications and long-term usage in chronic conditions.\n\nConclusion\n\nHYDROXENA 500 (Hydroxyurea 500 mg Capsule) is a powerful and effective medication used in the treatment of cancers and blood disorders such as sickle cell anemia, leukemia, and polycythemia vera. Its proven mechanism of action.\n\n\n\n\n\n\n", "price": 131.0, "discountamount": 40.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "head", "Email", "growth", "WhatsApp", "frequency", "treatment", "HYDROXENA", "medication", "Hydroxyurea", "information", "blood tests", "sterispharma", "sterisonline", "cancer cells", "neck cancers", "Regular monitoring", "healthcare provider", "optimal effectiveness", "potential side effects", "painful sickle cell crises", "chronic myelogenous leukemia", "sickle cell anemia management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1531, "imageuri": "https://productimages.withfloats.com/actual/69df65caf36538a7ebbd4cc3.png", "tileimageuri": "https://productimages.withfloats.com/tile/69df65caf36538a7ebbd4cc3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T11:01:20.451Z", "updatedon": "2026-04-15T10:17:45.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//hydroxyurea-500-mg-capsule/1531", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "HYDROXENA 500", "category": "GENERAL RANGE", "tags": [ "hydroxyurea 500 mg uses", "hydroxyurea 500 mg price", "hydroxyurea capsules ip 500mg", "hydroxyurea 500 mg side effects", "hydroxyurea 500 mg capsule", "hydroxyurea 500 mg capsule uses in hindi", "hydroxyurea 500 mg capsule uses", "hydroxyurea 500 mg capsule price", "hydroxyurea 500 mg capsule price", "hydroxyurea 500 mg capsule side effects in hindi", "hydroxyurea 500 mg capsule brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662c5cd87f0960e14a2d3c5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "temozolomide 100mg capsule", "description": "TMOZOLMIDE 100\nTMOZOLMIDE 100 is a prescription-only Temozolomide 100 mg capsule, widely used in the treatment of certain types of brain tumors. Temozolomide belongs to a class of medicines known as alkylating agents, which work by interfering with the growth and spread of cancer cells in the body. It is especially important in the management of aggressive and difficult-to-treat brain cancers, where precise and targeted chemotherapy is required.\n\nTemozolomide is known for its ability to cross the blood–brain barrier, a protective layer that prevents many medicines from reaching the brain. This unique property makes TMOZOLMIDE 100 highly effective for tumors originating in or spreading to the brain. The capsule formulation allows accurate dosing and convenient oral administration, which can significantly improve patient compliance compared to injectable chemotherapy.\n\nTMOZOLMIDE 100 is commonly prescribed by oncologists and neurologists as part of a combined treatment approach, often alongside radiotherapy or other supportive therapies. Its role is to slow tumor progression, reduce cancer cell multiplication, and help improve survival outcomes when used as directed.\n\nUses of TMOZOLMIDE 100 (Temozolomide 100 mg Capsule)\n\nTMOZOLMIDE 100 is primarily used in the treatment of specific central nervous system (CNS) cancers. The most common medical uses include:\n\nGlioblastoma multiforme (GBM)\nUsed in newly diagnosed patients, usually in combination with radiotherapy, followed by maintenance therapy.\n\nAnaplastic astrocytoma\nPrescribed for patients whose tumors have progressed or returned after standard treatment.\n\nOther malignant gliomas\nIn selected cases, temozolomide may be used for related brain tumors based on oncologist evaluation.\n\nRecurrent brain tumors\nUsed when cancer reappears after initial surgery, radiation, or chemotherapy.\n\nBecause of its targeted action, TMOZOLMIDE 100 plays a critical role in modern neuro-oncology treatment protocols.\n\nHow TMOZOLMIDE 100 Works\n\nTemozolomide works by damaging the DNA of cancer cells. After oral administration, temozolomide is rapidly absorbed and converted into its active form in the body. This active compound adds alkyl groups to the DNA of tumor cells, which:\n\nPrevents cancer cells from dividing\n\nTriggers cell death (apoptosis)\n\nSlows tumor growth and spread\n\nCancer cells, especially fast-growing brain tumor cells, are more vulnerable to this DNA damage than normal cells. This selective action helps control the disease while minimizing damage to healthy tissues when used correctly.\n\nKey Benefits of TMOZOLMIDE 100\n1. Effective Brain Tumor Penetration\n\nOne of the biggest advantages of temozolomide is its ability to cross the blood–brain barrier. This ensures that the medicine reaches the tumor site effectively.\n\n2. Proven Clinical Use\n\nTemozolomide has been widely studied and is internationally accepted as a standard treatment for malignant gliomas, particularly glioblastoma.\n\n3. Oral Chemotherapy Convenience\n\nTMOZOLMIDE 100 comes in capsule form, allowing patients to take chemotherapy orally instead of undergoing frequent injections or infusions.\n\n4. Compatible with Radiotherapy\n\nIt is commonly used alongside radiation therapy, where it enhances the overall effectiveness of cancer treatment.\n\n5. Flexible Dosing\n\nAvailable in multiple strengths, including 100 mg, allowing oncologists to customize dosing based on patient weight, condition, and treatment phase.\n\n6. Improves Disease Control\n\nWhen used as prescribed, TMOZOLMIDE 100 can help slow disease progression and support longer-term management of aggressive brain tumors.\n\nSide Effects of TMOZOLMIDE 100\n\nLike all chemotherapy medicines, TMOZOLMIDE 100 can cause side effects. Not all patients experience the same effects, and many are manageable under medical supervision.\n\nCommon Side Effects\n\nNausea and vomiting\n\nLoss of appetite\n\nFatigue or weakness\n\nHeadache\n\nConstipation\n\nThese effects are usually temporary and may reduce as the body adjusts to the treatment.\n\nLess Common but Important Side Effects\n\nDecreased white blood cell count (risk of infections)\n\nLow platelet count (increased bleeding risk)\n\nAnemia\n\nHair thinning or hair loss\n\nSkin rashes\n\nSerious Side Effects (Require Medical Attention)\n\nSevere infections due to low immunity\n\nPersistent fever\n\nUnusual bruising or bleeding\n\nShortness of breath\n\nSevere allergic reactions\n\nRegular blood tests are usually recommended during treatment to monitor blood cell counts and liver function.\n\nPrecautions and Safety Information\n\nTMOZOLMIDE 100 should only be taken under strict medical supervision.\n\nPregnant or breastfeeding women should avoid this medicine unless clearly advised by a doctor.\n\nEffective contraception is recommended during treatment.\n\nPatients should inform their doctor about all other medicines they are taking.\n\nCapsules should be swallowed whole and not opened or crushed.\n\nConclusion\n\nTMOZOLMIDE 100 (Temozolomide 100 mg Capsule) is a critical and well-established chemotherapy medicine used in the treatment of malignant brain tumors. Its ability to cross the blood–brain barrier, combined with its proven effectiveness and oral convenience, makes it a cornerstone therapy in neuro-oncology.", "price": 6937.0, "discountamount": 2081.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "pets", "dose", "light", "cycle", "Email", "reach", "types", "100mg", "liver", "Order", "nausea", "doctor", "severe", "adults", "Storage", "42 days", "fatigue", "capsule", "patients", "response", "appetite", "vomiting", "decrease", "bleeding", "moisture", "children", "WhatsApp", "headache", "hair loss", "pregnancy", "infection", "TMOZOLMIDE", "monitoring", "Precautions", "Indications", "unborn baby", "constipation", "sterispharma", "sterisonline", "Temozolomide", "brain tumors", "package insert", "brief overview", "Administration", "increased risk", "kidney problems", "other treatments", "room temperature", "blood cell counts", "active ingredient", "medical condition", "drug interactions", "28-day rest period", "dosage adjustments", "Common side effects", "detailed information", "healthcare professional", "glioblastoma multiforme", "chemotherapy medication", "persistent side effects", "effective contraception", "potential adverse effects", "refractory anaplastic astrocytoma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1513, "imageuri": "https://productimages.withfloats.com/actual/667d3cc45443982e2f655647.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3cc45443982e2f655647.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:33:17.608Z", "updatedon": "2026-03-12T08:06:38.861Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//temozolomide-100mg-capsule/1513", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TMOZOLMIDE 100", "category": "NEPHROLOGYRANGE", "tags": [ "temozolomide 100mg side effects", "temozolomide 100mg hindi", "temozolomide 100mg price", "", "temozolomide 100mg price in india", "temozolomide 100mg capsule", "temozolomide 100 mg capsules IP", "temozolomide 100mg tablet uses", "temozolomide 100mg price in india", "temozolomide 100mg composition", "temozolomide 100mg chemotherapy capsule", "temozolomide 100mg for brain tumor", "temozolomide 100mg for brain cancer", "temozolomide 100mg uses in cancer", "temozolomide medicine for brain tumor", "buy temozolomide 100mg online", "temozolomide 100mg capsule price", "temozolomide 100mg supplier India", "temozolomide 100mg manufacturer", "temozolomide 100mg wholesale price", "what is temozolomide 100mg used for", "is temozolomide 100mg chemotherapy", "how effective is temozolomide 100mg", "temozolomide 100mg capsule benefits" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a57d8da3a81d5c6a17dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mycophenolate mofetil 500mg", "description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n\n\n\nMycophenolate mofetil 500 mg stands as a cornerstone in modern immunosuppressive therapy, primarily designed to prevent organ transplant rejection in kidney, heart, and liver recipients. As a prodrug, it rapidly converts to its active form, mycophenolic acid (MPA), which selectively targets the proliferation of T and B lymphocytes—key players in immune responses that can attack transplanted organs. This medication, available in convenient 500 mg tablets, offers reliable protection against acute rejection episodes, making it an essential component in post-transplant regimens worldwide.​\n\nProduct Uses\nMycophenolate mofetil 500 mg finds its primary application in solid organ transplantation, where it helps maintain long-term graft survival. For kidney transplant patients, it is typically administered alongside corticosteroids and calcineurin inhibitors like cyclosporine or tacrolimus to suppress the immune system's overreaction to the new organ. In heart and liver transplants, it plays a similar role, reducing the incidence of rejection by inhibiting antibody production and cell-mediated immunity.​\n\nBeyond transplants, healthcare providers increasingly use mycophenolate mofetil 500 mg for various autoimmune conditions. It effectively manages lupus nephritis by curbing inflammation in the kidneys, showing superior efficacy over traditional therapies in preserving renal function. Rheumatoid arthritis patients benefit from its ability to dampen joint inflammation, while those with dermatomyositis or scleroderma experience reduced skin and muscle involvement. Off-label, it treats inflammatory bowel diseases like Crohn's disease and even certain skin disorders such as pemphigus vulgaris, where immune-mediated blistering threatens quality of life.​\n\nKey Benefits\nThe therapeutic advantages of mycophenolate mofetil 500 mg extend far beyond basic immunosuppression, offering patients enhanced outcomes and improved daily living.\n\nSuperior Graft Protection: Clinical data highlight reduced acute rejection rates by up to 50% when combined with standard regimens, leading to better long-term organ function and survival.​\n\nSelective Lymphocyte Targeting: By depleting guanosine nucleotides in T and B cells via inosine monophosphate dehydrogenase (IMPDH) inhibition, it spares other cell types, minimizing broad toxicity seen with older immunosuppressants.​\n\nAnti-Inflammatory Effects: MPA inhibits adhesion molecule glycosylation, preventing lymphocyte recruitment to inflamed sites, which alleviates symptoms in autoimmune flares.​\n\nOral Convenience: The 500 mg formulation allows flexible dosing—typically 1 gram twice daily—without the need for injections, improving patient adherence.​\n\nVersatility Across Conditions: Proven efficacy in lupus, vasculitis, and myositis expands its utility, often allowing steroid dose reduction and fewer relapses.​\n\nCardiovascular and Anticancer Potential: Emerging evidence suggests it delays graft atherosclerosis by reducing lipid oxidation and may hinder tumor progression in certain malignancies due to its impact on nucleotide synthesis.​\n\nThese benefits translate to fewer hospital readmissions, better quality of life, and cost savings in long-term care for transplant and autoimmune patients.​\n\nSide Effects\nWhile mycophenolate mofetil 500 mg provides robust immunosuppression, it carries risks typical of this drug class, necessitating vigilant monitoring.\n\nCommon side effects affect the gastrointestinal tract most prominently, with nausea, vomiting, diarrhea, and abdominal pain occurring in over 30% of users. These often improve with dose adjustments or enteric-coated alternatives, but hydration and antiemetics help manage them effectively.​\n\nHematologic issues like leukopenia, anemia, and thrombocytopenia arise due to bone marrow suppression, requiring regular complete blood counts—weekly initially, then monthly. Infections pose a significant threat, as suppressed immunity increases susceptibility to viral (e.g., CMV), bacterial, and fungal pathogens; prophylactic antivirals are standard.​\n\nLess frequent but notable effects include hypertension, tremor, insomnia, and elevated liver enzymes. Women face heightened risks of congenital malformations if used during pregnancy, mandating effective contraception and pregnancy testing. Rare severe reactions encompass progressive multifocal leukoencephalopathy (PML) from JC virus reactivation and hypersensitivity syndromes.​\n\nDosage and Administration Notes\nStandard dosing for renal transplants involves 1 gram (two 500 mg tablets) twice daily, starting within 72 hours post-surgery, with adjustments for renal impairment. Hepatic transplant patients may require higher initial doses due to metabolism differences. Always take on an empty stomach with water to optimize absorption, avoiding antacids that bind MPA.​\n\nPrecautions and Interactions\nPatients must avoid live vaccines, report fevers promptly, and undergo TB screening pre-treatment. Drug interactions with azathioprine, cholestyramine, or rifampin can alter levels, so pharmacists review regimens closely. Regular monitoring of MPA blood levels ensures therapeutic efficacy without toxicity.​\n\nConclusion\nMycophenolate mofetil 500 mg emerges as a transformative immunosuppressive agent, safeguarding transplanted organs and taming autoimmune storms with its precise mechanism of lymphocyte suppression and anti-inflammatory prowess. By delivering key benefits like reduced rejection, versatile applications, and manageable administration, it empowers patients to reclaim normalcy post-transplant or amid chronic illness. Despite potential side effects, proactive monitoring and personalized dosing mitigate risks, underscoring its value in contemporary medicine. For those navigating transplant recovery or autoimmune challenges, this medication offers hope and stability, backed by decades of clinical validation.\n\n", "price": 775.0, "discountamount": 256.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "Call", "harm", "risk", "Email", "heart", "ORDER", "nausea", "kidney", "dosage", "doctor", "vomiting", "WhatsApp", "Patients", "diarrhea", "rejection", "infections", "500mg dose", "combination", "information", "sterisonline", "proliferation", "B lymphocytes", "abdominal pain", "pregnant women", "immune response", "developing fetus", "other medications", "liver transplants", "other complications", "healthcare provider", "Common side effects", "organ transplantation", "Mycophenolate mofetil", "immunosuppressive drug", "Mycoplasm M 500 therapy", "healthcare professional", "other immunosuppressants", "immunosuppressive effects", "potential adverse effects", "optimal therapeutic outcomes", "gastrointestinal disturbances", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1472, "imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:03:09.216Z", "updatedon": "2026-03-12T08:00:39.14Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mycophenolate-mofetil-500mg/1472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 500", "category": "NEPHROLOGYRANGE", "tags": [ "MYCOPLASM M 500", "Mycophenolate mofetil (500mg)", "Mycophenolate mofetil 500 mg tablet", "Mycophenolate mofetil 500 mg price", "Mycophenolate mofetil 500 mg dosage", "Mycophenolate mofetil uses", "Mycophenolate mofetil side effects", "mycophenolate mofetil 500mg tablet uses", "mycophenolate mofetil 500mg dosage for kidney transplant", "mycophenolate mofetil 500mg for autoimmune disease" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6635ed538e18ce14f428c0c1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tofacitinib 11 mg", "description": "TACOTINIB ER 11 \nTACOTINIB ER 11 (Tofacitinib 11 mg Extended Release) – Comprehensive Product Overview\n\nTACOTINIB ER 11 contains Tofacitinib 11 mg in an extended-release formulation designed for convenient once-daily dosing. Tofacitinib belongs to a class of medicines known as Janus kinase (JAK) inhibitors. It works by modulating the immune system to reduce inflammation and control symptoms in certain autoimmune conditions. TACOTINIB ER 11 is prescribed under medical supervision to help patients manage chronic inflammatory diseases effectively and improve quality of life.\n\nWhat is Tofacitinib 11 mg?\n\nTofacitinib is an oral targeted synthetic disease-modifying anti-rheumatic drug (tsDMARD). Unlike traditional immunosuppressive therapies, it specifically blocks JAK enzymes involved in the inflammatory signaling pathway. By inhibiting these pathways, TACOTINIB ER 11 reduces the overactive immune response responsible for joint damage, swelling, pain, and other systemic symptoms.\n\nThe extended-release (ER) 11 mg formulation ensures a steady release of medication over 24 hours, maintaining consistent blood levels while improving convenience compared to twice-daily immediate-release options.\n\nIndications and Uses of TACOTINIB ER 11\n\nTACOTINIB ER 11 is commonly prescribed for the management of:\n\n1. Rheumatoid Arthritis (RA)\n\nA chronic autoimmune condition that causes inflammation in the joints, leading to pain, stiffness, swelling, and progressive joint damage. Tofacitinib helps reduce inflammation and slow structural damage.\n\n2. Psoriatic Arthritis (PsA)\n\nAn inflammatory arthritis associated with psoriasis. TACOTINIB ER 11 helps manage joint symptoms and improves physical function.\n\n3. Ulcerative Colitis (UC)\n\nA chronic inflammatory bowel disease affecting the colon. Tofacitinib may help reduce intestinal inflammation and induce remission in moderate to severe cases.\n\n4. Ankylosing Spondylitis (AS) (as advised by a physician)\n\nMay be used in selected patients where other treatments are not effective.\n\nTreatment should always be initiated and monitored by a qualified healthcare professional.\n\nHow TACOTINIB ER 11 Works\n\nTACOTINIB ER 11 targets intracellular signaling pathways involved in immune cell activation. By blocking Janus kinase enzymes (JAK1 and JAK3 primarily), it prevents the transmission of pro-inflammatory cytokine signals. This results in:\n\nReduced joint inflammation\n\nDecreased immune overactivity\n\nRelief from pain and stiffness\n\nSlowing of disease progression\n\nBecause it acts on immune pathways, regular medical monitoring is required during treatment.\n\nKey Benefits of TACOTINIB ER 11\n✔ Effective Inflammation Control\n\nReduces swelling, pain, and tenderness in affected joints or tissues.\n\n✔ Improved Physical Function\n\nEnhances mobility and daily activity performance in patients with rheumatoid or psoriatic arthritis.\n\n✔ Convenient Once-Daily Dosing\n\nExtended-release 11 mg formulation improves patient compliance.\n\n✔ Targeted Mechanism of Action\n\nSpecifically inhibits JAK pathways, offering a modern therapeutic approach.\n\n✔ Reduced Disease Progression\n\nHelps prevent long-term structural joint damage when used appropriately.\n\n✔ Oral Administration\n\nUnlike some biologic therapies, TACOTINIB ER 11 is taken orally, eliminating the need for injections.\n\nDosage and Administration\n\nThe usual recommended dose is one tablet (11 mg) once daily, or as prescribed by your physician.\n\nTablets should be swallowed whole with water.\n\nDo not crush, chew, or split the tablet.\n\nCan be taken with or without food.\n\nDosage adjustments may be required in patients with liver impairment, kidney problems, or when used alongside certain medications.\n\nPossible Side Effects of TACOTINIB ER 11\n\nLike all medications, TACOTINIB ER 11 may cause side effects. Not everyone experiences them, but it is important to be aware of potential risks.\n\nCommon Side Effects:\n\nUpper respiratory tract infections\n\nHeadache\n\nDiarrhea\n\nNausea\n\nIncreased cholesterol levels\n\nMild increase in liver enzymes\n\nSerious Side Effects:\n\nSerious infections (tuberculosis, bacterial, viral, or fungal infections)\n\nBlood clots (deep vein thrombosis or pulmonary embolism)\n\nCardiovascular events in high-risk individuals\n\nReduced white blood cell count\n\nIncreased risk of certain cancers (with long-term use)\n\nSeek immediate medical attention if you experience:\n\nPersistent fever\n\nShortness of breath\n\nChest pain\n\nSevere abdominal pain\n\nUnusual bruising or bleeding\n\nRegular blood tests are required to monitor liver function, cholesterol levels, and blood cell counts during treatment.\n\nPrecautions and Warnings\n\nBefore starting TACOTINIB ER 11, inform your doctor if you:\n\nHave a history of recurrent infections\n\nHave liver or kidney disease\n\nHave tuberculosis or hepatitis\n\nAre pregnant or planning pregnancy\n\nAre breastfeeding\n\nHave a history of blood clots or cardiovascular disease\n\nVaccinations should be updated before initiating therapy. Live vaccines are generally not recommended during treatment.\n\nDrug Interactions\n\nTACOTINIB ER 11 may interact with:\n\nStrong CYP3A4 inhibitors (e.g., certain antifungals)\n\nImmunosuppressive drugs\n\nBiologic DMARDs\n\nCertain antibiotics\n\nAlways inform your healthcare provider about all medications and supplements you are taking.\n\nStorage Instructions\n\nStore below 25°C in a dry place\n\nProtect from moisture and direct sunlight\n\nKeep out of reach of children\n\nWho Should Avoid TACOTINIB ER 11?\n\nThis medication may not be suitable for:\n\nPatients with active serious infections\n\nIndividuals with severe liver impairment\nPatients at high risk of blood clots without proper medical supervision\nA detailed medical evaluation is necessary before starting therapy.\n\nConclusion\nTACOTINIB ER 11 (Tofacitinib 11 mg Extended Release) is an advanced oral treatment option for managing moderate to severe autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. By targeting JAK pathways, it effectively reduces inflammation, improves mobility, and enhances overall quality of life.\n", "price": 795.0, "discountamount": 239.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "class", "headache", "response", "guidance", "monitoring", "medication", "TACOTINIB ER", "inflammation", "Janus kinase", "immune system", "joint function", "JAK) inhibitors", "sustained relief", "prescribed dosage", "healthcare provider", "psoriatic arthritis", "Common side effects", "rheumatoid arthritis", "extended-release formulation", "Tofacitinib Extended Release", "gastrointestinal disturbances", "upper respiratory tract infections" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1102, "imageuri": "https://productimages.withfloats.com/actual/6635ed8ae837fe0918c055ff.png", "tileimageuri": "https://productimages.withfloats.com/tile/6635ed8ae837fe0918c055ff.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-04T08:09:55.768Z", "updatedon": "2026-03-14T06:26:01.73Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tofacitinib-11-mg/1102", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TACOTINIB ER 11", "category": "ORTHOLOGYRANG", "tags": [ "tofacitinib 11 mg", "tofacitinib 11 mg tablet", "tofacitinib 11 mg price", "tab tofacitinib 11 mg", "tofacitinib 11 mg uses", "Tofacitinib 11 mg extended release tablets", "Tofacitinib 11 mg ER for psoriatic arthritis treatment", "Tofacitinib 11 mg tablet uses and benefits", "Tofacitinib 11 mg ER dosage guide", "Tofacitinib 11 mg side effects and precautions", "Tofacitinib 11 mg daily autoimmune treatment" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662ba161f7fe09029cbf518e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Temozolomide 100mg", "description": "TMOZOLMIDE 100\nTemodal 100mg Capsule stands as a cornerstone in oncology, specifically formulated with temozolomide 100mg to combat aggressive brain tumors like glioblastoma multiforme (GBM) and anaplastic astrocytoma. This oral alkylating agent crosses the blood-brain barrier effectively, delivering targeted chemotherapy that disrupts cancer cell DNA replication, halting tumor progression in adults with newly diagnosed or recurrent cases. Patients and caregivers often seek Temodal 100mg for its role in standard-of-care regimens, combining seamlessly with radiotherapy for enhanced survival outcomes in high-grade gliomas.​\n\nManufactured to rigorous standards, Temodal 100mg offers convenient capsule dosing, swallowed whole on an empty stomach to maximize bioavailability. Its proven track record in clinical settings makes it indispensable for neuro-oncology, where timely intervention can extend quality life years amid challenging diagnoses.​\n\nProduct Uses and Mechanism of Action\nTemodal 100mg Capsule primarily treats adult patients with newly diagnosed glioblastoma multiforme alongside radiotherapy, followed by maintenance monotherapy to prevent relapse. It also addresses refractory anaplastic astrocytoma—tumors that progress despite prior therapies—and recurrent malignant gliomas in children over three years, including brainstem glioma and high-grade astrocytoma.​\n\nThe mechanism hinges on temozolomide's rapid conversion to the active metabolite MTIC (5-(3-methyltriazen-1-yl)imidazole-4-carboxamide) at physiological pH, which methylates DNA at O6 and N7 guanine positions. This methylation induces DNA strand breaks during replication, triggering apoptosis in rapidly dividing glioma cells while sparing normal brain tissue to a degree. Unlike intravenous chemotherapies, Temodal 100mg achieves therapeutic CNS concentrations without specialized delivery, ideal for outpatient management.​\n\nIn practice, concomitant phase dosing (75 mg/m² daily with RT for 42 days) transitions to cycles of 150-200 mg/m² on days 1-5 every 28 days, tailored by body surface area and toxicity monitoring. This cyclical approach balances efficacy against cumulative myelosuppression, supporting long-term tumor control.​\n\nKey Benefits of Temodal 100mg Capsule\nTemodal 100mg delivers transformative benefits grounded in landmark trials:\n\nSuperior Survival in GBM: Concomitant temozolomide with RT extends median survival from 12.1 to 14.6 months, with 2-year survival rising from 10% to 26% per pivotal Phase III data.​\n\nMaintenance Therapy Efficacy: Post-RT cycles sustain progression-free survival up to 6-12 months in responders, delaying recurrence in MGMT-methylated tumors.​\n\nConvenient Oral Administration: Eliminates hospital visits, improving compliance for patients undergoing radiotherapy; rapid absorption (peak in 1 hour) ensures consistent exposure.​\n\nBlood-Brain Barrier Penetration: Achieves 30-40% cerebrospinal fluid levels, outperforming many alkylators in CNS malignancies.​\n\nPediatric Applicability: Effective in recurrent pediatric gliomas, with tolerance mirroring adults for ages 3+.​\n\nThese advantages position Temodal 100mg as a first-line essential, particularly for newly diagnosed cases where every month counts toward preserving cognitive function and independence.​\n\nReal-world use extends to off-label scenarios like metastatic melanoma or high-risk meningiomas under specialist oversight, though primary indications remain brain tumors. Its stability in acidic environments enhances reliability during storage and transit.​\n\nSide Effects of Temodal 100mg Capsule\nWhile Temodal 100mg offers life-prolonging potential, its myelotoxic profile demands vigilant hematologic monitoring. Common effects stem from DNA damage in rapidly proliferating bone marrow cells, peaking mid-cycle.​\n\nCommon Side Effects\nHematologic Toxicity: Neutropenia, thrombocytopenia (platelet nadir day 21-28), lymphopenia, and anemia affect 10-20%; febrile neutropenia occurs in vulnerable patients.​\n\nGastrointestinal Issues: Nausea (up to 50%), vomiting, constipation—mitigated by antiemetics like ondansetron taken 30 minutes prior.​\n\nNeurologic Symptoms: Fatigue, headache, ataxia, dizziness, or amnesia-like effects, often transient and RT-attributable.​\n\nOther: Alopecia, anorexia, rash, or elevated liver enzymes resolving post-cycle.​\n\nProphylactic measures like dose delays (if platelets <100 x 10⁹/L or neutrophils <1.5 x 10⁹/L) maintain tolerability; supportive care ensures most complete therapy.​\n\nSerious Side Effects\nRare but critical risks include:\n\nPancytopenia or Aplastic Anemia: Prolonged suppression risking infections or bleeding—mandatory weekly CBCs in early cycles.​\n\nSecondary Malignancies: Myeloid leukemia post-treatment (latency 1-5 years), hepatitis B reactivation.​\n\nOpportunistic Infections: Pneumocystis jirovecii pneumonia (PJP) prophylaxis with TMP-SMX recommended due to grade 3/4 lymphopenia.​\n\nNeurologic Deterioration: Status epilepticus, hemiplegia in advanced disease.​\n\nDiscontinue if non-hematologic CTC grade >2 persists; pregnant women face fetal toxicity—use contraception during and 6 months post-therapy.​\n\nDosage and Administration Guidelines\nInitiate Temodal 100mg at 75 mg/m² daily during RT (up to 49 days), escalating to 150 mg/m² (cycle 1) or 200 mg/m² (subsequent) for 5 days/23 off. Adjust downward for toxicity; hepatic/renal impairment rarely necessitates change unless severe. Capsules (5,20,100,250mg strengths) enable precise BSA-based dosing—e.g., ~100mg capsule for 70kg/m² patients.​\n\nPrecautions and Substitutes\nMonitor pregnancy status; avoid live vaccines. Substitutes include generic temozolomide capsules matching bioequivalence, though Temodal 100mg remains the reference standard. Interactions with valproic acid reduce clearance—increase dose 40% if co-administered.​\n\nConclusion\nTemodal 100mg Capsule empowers patients against glioblastoma's relentless advance, blending potent antineoplastic action with manageable administration for meaningful survival gains. From halting tumor growth via strategic DNA alkylation to fitting seamlessly into multimodal care, it embodies hope amid adversity—always under oncologist guidance to navigate toxicities and optimize outcomes. Embrace informed treatment; lives extend beyond statistics with vigilant care.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 7400.0, "discountamount": 2220.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "body", "types", "drugs", "class", "nausea", "spread", "growth", "surgery", "fatigue", "vomiting", "capsules", "TMOZOLMIDE", "instructions", "Temozolomide", "cancer cells", "brain tumors", "glioblastoma", "unusual symptoms", "potent medication", "other medications", "radiation therapy", "blood cell counts", "healthcare provider", "Common side effects", "comprehensive treatment plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 773, "imageuri": "https://productimages.withfloats.com/actual/662ba164481840e7a7fdadc0.png", "tileimageuri": "https://productimages.withfloats.com/tile/662ba164481840e7a7fdadc0.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:43:13.957Z", "updatedon": "2026-03-12T08:07:02.773Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//temozolomide-100mg/773", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TMOZOLMIDE 100", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6ae5d554245214b8e9f4b2fe", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Combipack of Amoxicillin Tablets USP,Omeprazole Capsules IP & Tinidazole Tablets IP", "description": "PANTOSTRUM OME HP KIT is a three-in-one combipack of Amoxicillin 750 mg Tablets USP, Omeprazole 20 mg Capsules IP, and Tinidazole 500 mg Tablets IP. Each component acts differently, and a doctor may prescribe them together for certain stomach and gut conditions. The kit is meant to be used only on a qualified physician’s advice.\n\nWhat Is Inside the Kit\nComponent\tDrug class\tPrimary role\nAmoxicillin 750 mg Tablets USP\tPenicillin-type antibiotic\tActs against susceptible bacteria\nOmeprazole 20 mg Capsules IP\tProton Pump Inhibitor (PPI)\tLowers stomach acid\nTinidazole 500 mg Tablets IP\tNitroimidazole antimicrobial\tActs against certain anaerobic bacteria and protozoa\nAmoxicillin 750 mg\n\nAmoxicillin is a broad-spectrum antibiotic from the penicillin family. It blocks bacteria from building their cell walls, so the bacteria cannot survive. Within a multi-drug regimen, it targets susceptible bacteria linked to gastrointestinal infection. Whether to use it is the prescriber’s decision, guided by antibiotic stewardship guidelines.\n\nOmeprazole 20 mg\n\nOmeprazole is a PPI. It switches off the proton pumps in the stomach lining that produce acid, so the stomach becomes less acidic. It is widely used for acid-related conditions such as GERD and peptic ulcer disease. In a combination regimen, lower acid levels can support the overall treatment.\n\nTinidazole 500 mg\n\nTinidazole belongs to the nitroimidazole group. It damages the DNA of susceptible anaerobic bacteria and protozoa, which stops them from multiplying. It is prescribed for specific infections under medical supervision, and in this kit it adds a further antimicrobial effect where clinically suitable.", "price": 125.0, "discountamount": 37.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2507, "imageuri": "https://productimages.withfloats.com/actual/6ae5d5567b5622859fa6fbd0.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ae5d5567b5622859fa6fbd0.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-31T11:47:32.806Z", "updatedon": "2026-10-31T11:47:32.806Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//combipack-of-amoxicillin-tablets-usp-omeprazole-capsules-ip-tinidazole-tablets-ip/2507", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PANTOSTRUM OME HP KIT", "category": null, "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
treatment of low platelet counts?

Still searching for
treatment of low platelet counts?

Chat with us